APOE2: How This Gene Variant Protects Against Alzheimer’s and Aging

People carrying the APOE2 form of the apolipoprotein E gene tend to live longer and have a lower risk of Alzheimer’s disease, yet the biological mechanics behind this natural advantage have remained largely unknown. A study published in Aging Cell by researchers at the Buck Institute for Research on Aging reveals that APOE2 helps neurons protect their genetic material and resist cellular senescence, a damaged, poorly functioning cellular state linked to neurodegeneration.

Unlocking the APOE2 Longevity Advantage

Scientists have known about the health benefits of the APOE2 variant for years through population studies, but the exact cellular pathways provided a black box, according to senior author Lisa M. Ellerby, PhD, professor at the Buck Institute. The new research demonstrates that neurons carrying APOE2 are better at preventing and repairing DNA damage, and they resist the cellular aging program that drives so much of late-life decline.

Unlike familiar studies fixating largely on lipid handling and amyloid-beta biology, this project connects a major longevity gene directly to core hallmarks of aging. “By showing that APOE alleles also tune how neurons defend their genome, this study connects a major longevity gene to two of the most actively studied hallmarks of aging,” Ellerby explains.

How the Buck Institute Study Compared APOE Variants

The apolipoprotein E gene exists in three common forms—APOE2, APOE3, and APOE4—which differ by only two amino acids. While APOE4 is the strongest known genetic risk factor for late-onset Alzheimer’s disease (typically after age 65), APOE2 has repeatedly been linked in population studies to longer life and a reduced risk of dementia.

To study these effects, the research team used human induced pluripotent stem cells (iPSCs) genetically engineered so that they differed only at the APOE locus. Investigators turned these cells into inhibitory GABAergic neurons and excitatory glutamatergic neurons, alongside examining hippocampal tissue from older mice engineered to carry the human APOE2, APOE3, or APOE4 gene.

DNA Damage and Cellular Senescence in APOE2 Neurons

Direct measurements of DNA strand breaks showed that APOE2 neurons had significantly less DNA damage than neurons carrying the other gene variants. Bulk and single-cell RNA sequencing confirmed that APOE2 GABAergic neurons strongly activated pathways involved in DNA repair and damage response, whereas APOE4 neurons displayed patterns of gene activity associated with Alzheimer’s disease.

When exposed to radiation or the chemotherapy drug doxorubicin, excitatory APOE2 neurons showed lower levels of senescence markers, including p16 and CRYAB. These cells also had smaller nucleoli and better-preserved nuclear architecture, indicating they were maintaining a healthier internal structure.

Transferable Protection and Future Therapeutic Directions

Investigators tested whether the protective effect of the APOE2 protein could benefit neurons that carried APOE4. By adding recombinant APOE2 protein directly to APOE4 neurons, the team observed reduced DNA damage signaling following radiation exposure. This offers an early indication that at least part of the protective effect may be transferable rather than being limited to people born with the gene variant.

The mouse experiments produced a similar pattern. Older APOE2 knock-in mice had smaller nucleoli, higher levels of the nuclear scaffolding protein Lamin A/C, and better-preserved heterochromatin within the hippocampus compared to mice carrying APOE3 or APOE4.

Co-first author Cristian Gerónimo-Olvera, PhD, a postdoctoral fellow at the Buck Institute, highlighted the consistency of the results across two very different neuron types and across human cells and mouse brain tissue. Future work will investigate whether APOE2-mimetic compounds or targeted DNA repair treatments can provide similar protection in people with APOE4, the group with the highest genetic risk for Alzheimer’s disease.

Frequently Asked Questions

What is the APOE2 gene variant?

APOE2 is one of three common forms of the apolipoprotein E gene. It has repeatedly been linked in population studies to longer life and a reduced risk of dementia.

How does APOE2 protect brain cells?

According to research from the Buck Institute, APOE2 helps neurons protect their DNA and avoid senescence, a damaged, poorly functioning cellular state that becomes more common with age and is believed to contribute to neurodegeneration.

Can the protective effects of APOE2 be shared with other gene variants?

Laboratory tests adding recombinant APOE2 protein to APOE4 neurons showed reduced DNA damage signaling after radiation exposure, offering an early indication that the protective effect may be transferable.